Tesoro Filler with Lidocaine — Korean Cross-Linked HA Filler in Fine, Deep, Sub-Q & Implant

Tesoro Filler with Lidocaine is a Korean cross-linked hyaluronic acid dermal filler manufactured by BNC Global in Seoul, South Korea. All four variants share a 20 mg/mL stabilized HA base and 0.3% premixed lidocaine. The product line is built on BNC Global’s 3-phase HA purification process and is available in four variants — Fine, Deep, Sub-Q, and Implant — covering the full facial spectrum from superficial fine lines to non-surgical jawline contouring.

All four share 20 mg/mL HA and 0.3% lidocaine but differ in cross-linking density and intended injection layer. Tesoro Fine (27G + 30G) treats superficial fine lines, perioral wrinkles, and provides lip hydration. Tesoro Deep (2 × 27G) addresses nasolabial folds and adds “push-up” lip volume. Tesoro Sub-Q (25G + 27G) targets cheekbone, chin, temple, and nose dorsum. Tesoro Implant — the highest viscosity, supplied as a 2 × 1.1 mL pack — handles non-surgical facial sculpting including injection rhinoplasty and jawline contouring.

3-phase purification refers to BNC Global’s documented process where the hyaluronic acid base undergoes three sequential purification steps before being cross-linked into the final gel. Each phase reduces residual proteins and bacterial endotoxins. The result is a high-purity HA substrate that minimises immune response and lowers the documented rate of localised injection-site reactions — a safety-focused differentiator emphasised across the Tesoro product range.

Tesoro Implant is engineered for non-surgical facial sculpting — jawline contouring, chin augmentation, and injection rhinoplasty — anatomical zones that typically require more product per session than nasolabial folds or lip volume. The 2-syringe pack (1.1 mL each, total 2.2 mL) reduces the need for multiple boxes during a single contour treatment, improving session efficiency for the practitioner. Migration resistance is also engineered specifically into this variant for sustained shape retention.

Duration depends on the variant chosen and the anatomical site treated. Tesoro Fine in superficial dermis typically delivers shorter duration than the deeper variants. Tesoro Sub-Q and Implant — placed in subcutaneous and supraperiosteal layers with lower tissue metabolism — deliver longer durability. Most cross-linked HA fillers in this concentration range provide 8–18 months depending on placement, dose, patient metabolism, and facial movement intensity.

Tesoro Filler is manufactured by BNC Global, a Korean medical device company based in Seoul, South Korea. BNC Global also produces the Tesoro Rouge lip filler — a related but distinct product with a higher 26 mg/mL HA concentration and an added pink-tint formulation. Both share the same 3-phase HA purification framework but are positioned for different clinical applications.

Tesoro Filler is KFDA registered in South Korea. It is not currently FDA approved in the United States. CE marking status should be confirmed with BNC Global for the specific jurisdiction. Regulatory approval varies by country and changes over time — buyers are responsible for verifying that import and clinical use are permitted in their region before ordering.

Yes — combining Tesoro variants in a full-face protocol is standard practice. A typical session might use Tesoro Implant for jawline and chin contour, Tesoro Sub-Q for cheekbone augmentation, Tesoro Deep for nasolabial folds, and Tesoro Fine for perioral fine lines. Because all four variants share the same 20 mg/mL HA base and 3-phase purification, layered biocompatibility is consistent across the protocol.

Store between 2 °C and 25 °C, away from direct sunlight. Do not freeze. Shelf life is 24 months from the manufacturing date printed on the box. Once a syringe is opened, contents must be used immediately — partial syringes cannot be retained for later use.

No. Tesoro Filler uses non-animal hyaluronic acid produced by bacterial fermentation — the standard manufacturing approach for modern HA dermal fillers. The product contains no animal proteins or by-products, making it suitable for patients who avoid animal-derived medical products.